The weight loss drugs Diaries
Danish pharma giant Novo Nordisk on Wednesday claimed improved-than-predicted earnings for 2023, propelled by a tsunami of need for its blockbuster weight loss and diabetic issues drugs as new solutions arise and contend for any slice from the increasing sector.Semaglutide mimics the motion of the hormone—GLP-1—that is to blame for regulating u